Suit Claims Fosamax Caused Problems with Leg Bones

Contact a Fosamax Lawyer

or

January 29th, 2008

"Conn. Woman suffers from stress fractures and suppressed bone regeneration"

A new lawsuit has been filed against Merck & Co. over its osteoporosis drug Fosamax. The suit claims the drug caused a Connecticut woman to suffer multiple stress fractures in her legs as well as suppressed bone regeneration.

Merck is already facing hundreds of Fosamax lawsuits claiming the drug caused a rare and disfiguring condition known as osteonecrosis of the jaw (ONJ), or decay of the jawbone.

Fosamax is one of Merck’s top-selling drugs, generating nearly $3 billion in sales last year alone.

In November, the company announced a $4.85 settlement to cover tens of thousands of Vioxx lawsuits. Merck pulled Vioxx from the market in 2004 when evidence showed the drug caused potentially deadly heart problems.

Injured by Fosamax? Contact an experienced attorney near you today to learn more about recovering compensation for your losses.